Delivery Order SPE2DR25D2101-SPE2DR26F46CV
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, with a ceiling value of $1,093.68. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract was not set aside for any particular business category and was competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in...
- Amerisourcebergen Drug Corp has received a $3,116.34 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 120 tablets of the 500 mg Capecitabine pharmaceutical. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by the November 7, 2023 completion date. No set-aside designation was applied to this order, which was awarded against an indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of CAPECITABINE 500 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $1,597.40 firm fixed-price delivery order has an ultimate completion date of June 17, 2025 and was awarded on June 16, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Capecitabine 500 mg tablets in 120-count packages. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,404.00 and an ultimate completion date of October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,761.90 award is for the supply of 4563170212 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, with a completion date of December 26, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp has previously received numerous DLA contract awards...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,249.40 firm fixed price delivery order is for the supply of Capecitabine 500 mg tablets, a pharmaceutical product, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these tablets to the DLA Troop Support Medical in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for AKYNZEO 300-0.5 mg capsules valued at $5,541.20. This competitively awarded, firm fixed-price delivery order, issued on August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,539.30 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by June 3, 2025. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on August 28, 2025, from the Defense Logistics Agency's Medical Supply Chain for Candesartan Cilexetil 8 mg tablets (90-count). The contract is valued at $2,152.03 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. This non-set-aside award was competitively awarded and represents a child contract...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46CVDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency for Capecitabine 500 mg tablets (120-count units) valued at $1,009.98, with an ultimate completion date of December 4, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical supply across the Department of Defense healthcare system. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medications and medical commodities to support military and veteran healthcare systems worldwide. Capecitabine is a chemotherapy medication commonly used in oncology treatment protocols. Through its DLA relationship, the company provides an extensive portfolio of pharmaceutical products spanning multiple therapeutic domains, from specialty and generic medications to vaccines and medical devices. The SPE2DX contract serves as a flexible global pharmaceutical support vehicle enabling AmerisourceBergen to supply the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/2/25 |